Morgan Stanley’s Dermira, Inc. DERM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-116,614
| Closed | -$1.77M | – | 6883 |
|
|
2019
Q4 | $1.77M | Buy |
116,614
+85,782
| +278% | +$741K | ﹤0.01% | 4128 |
|
|
2019
Q3 | $198K | Buy |
30,832
+10,991
| +55% | +$91.8K | ﹤0.01% | 5142 |
|
|
2019
Q2 | $190K | Sell |
19,841
-40,709
| -67% | -$438K | ﹤0.01% | 5048 |
|
|
2019
Q1 | $820K | Sell |
60,550
-13,009
| -18% | -$108K | ﹤0.01% | 4250 |
|
|
2018
Q4 | $530K | Buy |
73,559
+13,148
| +22% | +$144K | ﹤0.01% | 4747 |
|
|
2018
Q3 | $658K | Sell |
60,411
-193,251
| -76% | -$1.95M | ﹤0.01% | 4827 |
|
|
2018
Q2 | $2.33M | Buy |
253,662
+123,004
| +94% | +$1.15M | ﹤0.01% | 3926 |
|
|
2018
Q1 | $1.04M | Buy |
130,658
+36,996
| +39% | +$805K | ﹤0.01% | 4516 |
|
|
2017
Q4 | $2.6M | Buy |
93,662
+29,810
| +47% | +$791K | ﹤0.01% | 3792 |
|
|
2017
Q3 | $1.72M | Buy |
63,852
+11,666
| +22% | +$305K | ﹤0.01% | 4024 |
|
|
2017
Q2 | $1.52M | Sell |
52,186
-24,452
| -32% | -$743K | ﹤0.01% | 4038 |
|
|
2017
Q1 | $2.61M | Buy |
76,638
+4,434
| +6% | +$143K | ﹤0.01% | 3570 |
|
|
2016
Q4 | $2.19M | Buy |
72,204
+65,564
| +987% | +$2.11M | ﹤0.01% | 3850 |
|
|
2016
Q3 | $224K | Buy |
6,640
+5,107
| +333% | +$164K | ﹤0.01% | 4961 |
|
|
2016
Q2 | $45K | Buy |
1,533
+642
| +72% | +$17.7K | ﹤0.01% | 5567 |
|
|
2016
Q1 | $18K | Sell |
891
-41,876
| -98% | -$1.03M | ﹤0.01% | 5959 |
|
|
2015
Q4 | $1.48M | Buy |
42,767
+19,299
| +82% | +$554K | ﹤0.01% | 3749 |
|
|
2015
Q3 | $548K | Buy |
23,468
+23,273
| +11,935% | +$565K | ﹤0.01% | 4545 |
|
|
2015
Q2 | $3K | Buy |
+195
| New | +$3.01K | ﹤0.01% | 6488 |
|
|
2015
Q1 | – | Sell |
-30,038
| Closed | -$544K | – | 6728 |
|
|
2014
Q4 | $544K | Buy |
+30,038
| New | +$502K | ﹤0.01% | 4598 |
|
Morgan Stanley's DERM Position: Q1 2020 in Review
Morgan Stanley sold out of Dermira, Inc. (DERM) in Q1 2020, closing a stake of 116,614 shares — an estimated $1.77M sold.
Morgan Stanley first reported a position in DERM in Q4 2014 and held it in 20 quarters. The position peaked at $2.61M in Q1 2017. 0 funds tracked by Wall St. Rank hold DERM as of Q1 2020.
- Morgan Stanley reported no remaining Dermira, Inc. position as of Q1 2020 after selling out during the quarter.
- Morgan Stanley sold 116,614 Dermira, Inc. shares in Q1 2020, an estimated $1.77M.
- Morgan Stanley first reported a position in Dermira, Inc. in Q4 2014 and held it in 20 quarters.
- Morgan Stanley's Dermira, Inc. position peaked at $2.61M in Q1 2017.
- 0 funds tracked by Wall St. Rank held Dermira, Inc. as of Q1 2020.
Based on Morgan Stanley's 13F filing for Q1 2020, filed 15 May 2020.